Experts worry early detection tests like Galleri and CancerGuard are unproven and could drive up health care costs by ...
OPERA-02: a phase 3 randomized, double-blind, active-controlled study of palazestrant with ribociclib versus letrozole with ribociclib for the first-line treatment of ER+, HER2- advanced breast cancer ...
Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted ...
For more information about the 14 th Annual Acute Leukemia Meeting, please visit the meeting website. About Moleculin Biotech, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback